Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Immuneering Corporation (IMRX)
USD5.15
-0.06 (-1.15%)
US NASDAQ Healthcare Biotechnology
Address
245 Main Street 2142
Cambridge, MA, US
Cambridge, MA, US
CEO
Benjamin J. Zeskind
Website
immuneering.com
IPO
2021-07-30
CIK 1790340 ISIN US45254E1073
Description
Immuneering Corporation is a biopharmaceutical company dedicated to developing novel therapeutic candidates in the fields of oncology (cancer) and neuroscience. Leading its clinical development efforts are two key drug candidates: IMM-1-104, a dual-MEK inhibitor intended for the treatment of various cancers, including pancreatic, melanoma, colorectal, and non-small cell lung cancer, specifically those driven by RAS and/or RAF gene mutations. The second is IMM-6-415, which is being developed to treat solid tumors. Beyond these advanced-stage programs, Immuneering's early-stage pipeline includes five oncology initiatives aimed at components of the MAPK or mTOR signaling pathways, along with two neuroscience programs, all currently in the discovery phase. Founded in 2008, Immuneering Corporation is headquartered in Cambridge, Massachusetts. It was formerly a subsidiary of Teva Pharmaceutical Industries Limited.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD5.15
-0.06 (-1.15%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.38
Float Shares
25.23M
Free Float %
69.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.39% | -1.53% | -7.19% | +0.78% | -25.43% | -21.58% | +239.47% | -40.42% | -70.67% | -70.67% | -70.67% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (11 ratings, all time)
Buy
Price Targets & DCF
Current price
5.15
Low
12.00
+133.0%
Consensus
12.00
+133.0%
Median
12.00
+133.0%
High
12.00
+133.0%
DCF (Unlevered)
2.80
-45.6%
DCF (Levered)
2.84
-44.9%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 4 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
12.00
+133.0%
|
| Last Year | 3 |
18.00
+249.5%
|
| All Time | 7 |
17.71
+243.9%
|
Quality scores
Altman Z-Score
-1.03
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+37.8% ★ Q1'26: +50.0% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%-120.0% Q1'26: -0.1% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+46.8% Q1'26: +82.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.07× Q1'26: -61.54× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 5 EPS Ana. |
Dec 2027 4 Rev. Ana. 5 EPS Ana. |
Dec 2028 3 Rev. Ana. 4 EPS Ana. |
Dec 2029 2 Rev. Ana. 2 EPS Ana. |
Dec 2030 1 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.08M
est: 2.44M (-14.9%)
|
317.0K
est: 447.4K (-29.2%)
|
—
|
—
est: 1.09M (-100.0%)
|
21.27M
21.27M – 21.27M
+1,855.6% YoY
|
16.00M
16.00M – 16.00M
-24.8% YoY
|
51.75M
51.75M – 51.75M
+223.4% YoY
|
109.07M
109.07M – 109.07M
+110.8% YoY
|
191.78M
191.78M – 191.78M
+75.8% YoY
|
| EBITDA |
-33.73M
est: -488.9K (-6,798.8%)
|
-51.47M
est: -89.5K (-57,415.9%)
|
-63.69M
|
-58.68M
est: 217.5K (-27,078.1%)
|
4.25M
4.25M – 4.25M
+1,855.6% YoY
|
3.20M
3.20M – 3.20M
-24.8% YoY
|
10.35M
10.35M – 10.35M
+223.4% YoY
|
21.81M
21.81M – 21.81M
+110.8% YoY
|
38.36M
38.36M – 38.36M
+75.8% YoY
|
| EBIT |
-33.89M
est: -488.9K (-6,831.4%)
|
-51.75M
est: -89.5K (-57,725.7%)
|
-64.07M
|
-59.38M
est: 217.5K (-27,399.4%)
|
4.25M
4.25M – 4.25M
+1,855.6% YoY
|
3.20M
3.20M – 3.20M
-24.8% YoY
|
10.35M
10.35M – 10.35M
+223.4% YoY
|
21.81M
21.81M – 21.81M
+110.8% YoY
|
38.36M
38.36M – 38.36M
+75.8% YoY
|
| Net Income |
-33.54M
est: -98.88M (+66.1%)
|
-50.51M
est: -57.91M (+12.8%)
|
-61.04M
est: -54.08M (-12.9%)
|
-56.02M
est: -63.03M (+11.1%)
|
-56.67M
-77.61M – -35.73M
+10.1% YoY
|
-58.14M
-66.16M – -50.12M
-2.6% YoY
|
-86.17M
-94.19M – 13.64M
-48.2% YoY
|
-28.04M
-28.04M – -28.04M
+67.5% YoY
|
2.73M
2.73M – 2.73M
+109.7% YoY
|
| SGA |
8.27M
est: 27.65M (-70.1%)
|
15.61M
est: 5.06M (+208.3%)
|
16.08M
|
17.30M
est: 12.23M (+41.5%)
|
239.11M
239.11M – 239.11M
+1,855.6% YoY
|
179.90M
179.90M – 179.90M
-24.8% YoY
|
581.86M
581.86M – 581.86M
+223.4% YoY
|
1.23B
1.23B – 1.23B
+110.8% YoY
|
2.16B
2.16B – 2.16B
+75.8% YoY
|
| EPS |
-1.27
est: -3.30 (+61.5%)
|
-1.87
est: -1.93 (+3.2%)
|
-2.04
est: -1.79 (-13.7%)
|
-1.27
est: -1.42 (+10.4%)
|
-1.14
-1.76 – -0.81
+19.5% YoY
|
-1.35
-1.50 – -1.14
-18.3% YoY
|
-1.21
-2.14 – 0.31
+10.1% YoY
|
-0.64
-0.64 – -0.64
+47.5% YoY
|
0.06
0.06 – 0.06
+109.7% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-01 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-45.34M
OE per share TTM
-1.18
Owner's Yield
-19.81%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
408.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
21
Total invested
4.77M
Insider transactions (90d)
0
Beneficial owners (>5%)
11
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Benjamin J. Zeskind | 3.36M | 12.70% | 2.46M | 894.9K | 2.46M | 894.9K | IN | United States | 2022-02-10 | ↗ |
| 2 | 52-0556948 | 3.19M | 12.20% | 545.4K | — | 3.19M | — | IA | Maryland | 2022-02-14 | ↗ |
| 3 | Merrin Investors LLC | 2.41M | 9.30% | 2.41M | — | 2.41M | — | OO | Delaware | 2021-08-11 | ↗ |
| 4 | Bihua Chen | 2.25M | 8.83% | — | 2.25M | — | — | IN | United States | 2021-08-13 | ↗ |
| 5 | Cormorant Asset Management, LP | 2.25M | 8.83% | — | 2.25M | — | — | PN | Delaware | 2021-08-13 | ↗ |
| 6 | (1) BlackRock, Inc. | 2.10M | 7.20% | 2.09M | — | 2.10M | — | HC | Delaware | 2024-01-26 | ↗ |
| 7 | Cormorant Private Healthcare Fund III, LP | 1.30M | 5.09% | — | 1.30M | — | — | PN | Delaware | 2021-08-13 | ↗ |
| 8 | Cormorant Private Healthcare GP III, LLC | 1.30M | 5.09% | — | 1.30M | — | — | OO | Delaware | 2021-08-13 | ↗ |
| 9 | Cormorant Global Healthcare GP, LLC | 937.7K | 3.68% | — | 937.7K | — | — | OO | Delaware | 2021-08-13 | ↗ |
| 10 | Cormorant Global Healthcare Master Fund, LP | 937.7K | 3.68% | — | 937.7K | — | — | PN | Cayman Islands | 2021-08-13 | ↗ |
| 11 | Kenneth Griffin | 6.00 | 8.00% | — | 2.06M | — | — | HC, IN | Delaware | 2021-08-13 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
21
-72 vs prev Q
New positions
8
Closed positions
74
Increased
15
Reduced
2
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | EMPERY ASSET MANAGEMENT, LP | 2.67M +2.7M (+100.0%) | 17.60B +17.6B (+100.0%) | 6.74% +6.743 pp | 15.52% +15.521 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 2 | FMR LLC | 9.69M +898.4K (+10.2%) | 63.73M +2.2M (+3.6%) | 24.42% -0.003 pp | 0.00% +0.000 pp | USD6.88 -4.4% | 3 qtrs — |
| 3 | SANOFI | 2.71M +— (+0.0%) | 17.82M -1.1M (-6.0%) | 6.83% -0.699 pp | 5.74% -1.541 pp | USD7.00 -6.0% | 2 qtrs — |
| 4 | VANGUARD GROUP INC | 2.57M +153.0K (+6.3%) | 16.90M -7.3K (0.0%) | 6.47% -0.238 pp | 0.00% +0.000 pp | USD8.98 -26.7% | 18 qtrs — |
| 5 | STATE STREET CORP | 2.40M +2.2M (+1,289.7%) | 15.81M +14.6M (+1,206.3%) | 6.06% +5.575 pp | 0.00% +0.001 pp | USD6.65 -1.1% | 18 qtrs — |
| 6 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.99M +195.2K (+10.9%) | 13.12M +529.0K (+4.2%) | 5.03% +0.028 pp | 0.00% +0.000 pp | USD6.96 -5.5% | 18 qtrs — |
| 7 | BLACKROCK, INC. | 1.45M +770.5K (+113.1%) | 9.55M +4.8M (+100.3%) | 3.66% +1.767 pp | 0.00% +0.000 pp | USD5.53 +19.0% | 6 qtrs — |
| 8 | MARSHALL WACE, LLP | 711.9K +440.6K (+162.4%) | 4.68M +2.8M (+146.6%) | 1.79% +1.041 pp | 0.00% +0.002 pp | USD4.66 +41.2% | 7 qtrs — |
| 9 | BLUE OWL CAPITAL HOLDINGS LP | 665.0K +115.0K (+20.9%) | 4.38M +525.7K (+13.7%) | 1.68% +0.148 pp | 0.33% -0.868 pp | USD6.93 -5.1% | 2 qtrs — |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 618.1K +104.4K (+20.3%) | 4.07M +471.1K (+13.1%) | 1.56% +0.131 pp | 0.00% +0.000 pp | USD8.28 -20.5% | 18 qtrs — |
| 11 | — | 498.5K +— (+0.0%) | 3.28M -209.4K (-6.0%) | 1.26% -0.129 pp | 2.28% +0.156 pp | USD7.00 -6.0% | 2 qtrs — |
| 12 | MORGAN STANLEY | 489.6K +194.8K (+66.1%) | 3.22M +1.2M (+56.1%) | 1.23% +0.415 pp | 0.00% +0.000 pp | USD5.17 +27.3% | 18 qtrs — |
| 13 | GOLDMAN SACHS GROUP INC | 318.8K +318.8K (+100.0%) | 2.10M +2.1M (+100.0%) | 0.80% +0.804 pp | 0.00% +0.000 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 14 | BURKEHILL GLOBAL MANAGEMENT, LP | 300.0K +— (+0.0%) | 1.97M -126.0K (-6.0%) | 0.76% -0.077 pp | 0.13% +0.011 pp | USD7.00 -6.0% | 2 qtrs — |
| 15 | SOUTHPORT MANAGEMENT, L.L.C. | 277.5K +5.0K (+1.8%) | 1.83M -81.6K (-4.3%) | 0.70% -0.058 pp | 6.37% -1.496 pp | USD3.08 +113.6% | 10 qtrs — |
| 16 | DIAMETRIC CAPITAL, LP | 246.9K -5.3K (-2.1%) | 1.62M -141.0K (-8.0%) | 0.62% -0.079 pp | 0.44% -0.219 pp | USD7.00 -6.0% | 2 qtrs — |
| 17 | BARCLAYS PLC | 230.7K +220.8K (+2,224.9%) | 1.52M +1.5M (+6,043.7%) | 0.58% +0.554 pp | 0.00% +0.000 pp | USD6.62 -0.6% | 16 qtrs — |
| 18 | DCF ADVISERS, LLC | 215.0K +215.0K (+100.0%) | 1.41M +1.4M (+100.0%) | 0.54% +0.542 pp | 0.38% +0.380 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 19 | BANK OF AMERICA CORP /DE/ | 214.3K +170.6K (+389.9%) | 1.41M +1.1M (+360.5%) | 0.54% +0.419 pp | 0.00% +0.000 pp | USD6.25 +5.3% | 18 qtrs — |
| 20 | TWO SIGMA INVESTMENTS, LP | 207.2K +99.3K (+92.0%) | 1.36M +608.0K (+80.5%) | 0.52% +0.222 pp | 0.00% +0.001 pp | USD6.30 +4.4% | 7 qtrs — |
| 21 | UBS GROUP AG | 190.3K +63.9K (+50.6%) | 1.25M +367.6K (+41.5%) | 0.48% +0.129 pp | 0.00% +0.000 pp | USD6.74 -2.4% | 8 qtrs — |
| 22 | QUBE RESEARCH & TECHNOLOGIES LTD | 165.9K +165.9K (+100.0%) | 1.09M +1.1M (+100.0%) | 0.42% +0.418 pp | 0.00% +0.001 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 23 | RENAISSANCE TECHNOLOGIES LLC | 152.3K +117.3K (+335.1%) | 1.00M +757.1K (+309.0%) | 0.38% +0.287 pp | 0.00% +0.001 pp | USD6.24 +5.4% | 3 qtrs — |
| 24 | 683 CAPITAL MANAGEMENT, LLC | 150.7K +150.7K (+100.0%) | 991.6K +991.6K (+100.0%) | 0.38% +0.380 pp | 0.04% +0.043 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 25 | CAPTION MANAGEMENT, LLC | 150.0K +150.0K (+100.0%) | 987.0K +987.0K (+100.0%) | 0.38% +0.378 pp | 0.01% +0.007 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 26 | WOODLINE PARTNERS LP | 150.0K +— (+0.0%) | 987.0K -63.0K (-6.0%) | 0.38% -0.039 pp | 0.00% -0.001 pp | USD7.00 -6.0% | 2 qtrs — |
| 27 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 132.7K +132.7K (+100.0%) | 873.0K +873.0K (+100.0%) | 0.33% +0.335 pp | 0.00% +0.002 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 28 | RAFFERTY ASSET MANAGEMENT, LLC | 130.7K +130.7K (+100.0%) | 860.3K +860.3K (+100.0%) | 0.33% +0.330 pp | 0.00% +0.003 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 29 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 120.4K +— (+0.0%) | 792.6K -50.6K (-6.0%) | 0.30% -0.031 pp | 0.02% -0.001 pp | USD3.87 +70.0% | 15 qtrs — |
| 30 | KINGSVIEW WEALTH MANAGEMENT, LLC | 118.6K +28.6K (+31.8%) | 780.4K +150.4K (+23.9%) | 0.30% +0.049 pp | 0.01% +0.002 pp | USD6.47 +1.7% | 3 qtrs — |
| 31 | TD ASSET MANAGEMENT INC | 117.8K -27.3K (-18.8%) | 775.4K -240.8K (-23.7%) | 0.30% -0.106 pp | 0.00% 0.000 pp | USD7.00 -6.0% | 18 qtrs — |
| 32 | HIGHTOWER ADVISORS, LLC | 111.3K -21.1K (-16.0%) | 732.5K -194.7K (-21.0%) | 0.28% -0.088 pp | 0.00% 0.000 pp | USD2.27 +189.9% | 10 qtrs — |
| 33 | NORTHERN TRUST CORP | 109.1K +17.0K (+18.5%) | 717.6K +73.3K (+11.4%) | 0.27% +0.019 pp | 0.00% +0.000 pp | USD8.38 -21.5% | 18 qtrs — |
| 34 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 107.5K +107.5K (+100.0%) | 707.2K +707.2K (+100.0%) | 0.27% +0.271 pp | 0.00% +0.000 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 35 | JANE STREET GROUP, LLC | 102.0K +102.0K (+100.0%) | 671.4K +671.4K (+100.0%) | 0.26% +0.257 pp | 0.00% +0.000 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 36 | SQUAREPOINT OPS LLC | 92.3K +92.3K (+100.0%) | 607.0K +607.0K (+100.0%) | 0.23% +0.233 pp | 0.00% +0.001 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 37 | CITADEL ADVISORS LLC | 90.5K -852.7K (-90.4%) | 595.2K -6.0M (-91.0%) | 0.23% -2.393 pp | 0.00% -0.001 pp | USD7.00 -6.0% | 2 qtrs — |
| 38 | HUDSON BAY CAPITAL MANAGEMENT LP | 85.0K -17.5K (-17.1%) | 559.1K -158.0K (-22.0%) | 0.21% -0.071 pp | 0.00% -0.001 pp | USD7.00 -6.0% | 2 qtrs — |
| 39 | LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 82.3K +82.3K (+100.0%) | 541.9K +541.9K (+100.0%) | 0.21% +0.208 pp | 0.04% +0.036 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 40 | PRELUDE CAPITAL MANAGEMENT, LLC | 80.0K +7.5K (+10.4%) | 526.4K +19.1K (+3.8%) | 0.20% +0.000 pp | 0.04% -0.001 pp | USD6.96 -5.5% | 2 qtrs — |
| 41 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 69.7K +464.0 (+0.7%) | 469.2K -15.8K (-3.2%) | 0.18% -0.017 pp | 0.00% +0.000 pp | USD7.00 -6.0% | 16 qtrs — |
| 42 | PALUMBO WEALTH MANAGEMENT LLC | 63.3K +14.2K (+29.0%) | 416.3K +73.0K (+21.3%) | 0.16% +0.023 pp | 0.10% -0.007 pp | USD6.91 -4.8% | 2 qtrs — |
| 43 | FOX RUN MANAGEMENT, L.L.C. | 51.8K +51.8K (+100.0%) | 340.7K +340.7K (+100.0%) | 0.13% +0.131 pp | 0.05% +0.053 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 44 | MILLENNIUM MANAGEMENT LLC | 50.9K -185.9K (-78.5%) | 335.1K -1.3M (-79.8%) | 0.13% -0.530 pp | 0.00% -0.001 pp | USD5.85 +12.5% | 9 qtrs — |
| 45 | OMERS ADMINISTRATION CORP | 47.8K +47.8K (+100.0%) | 314.5K +314.5K (+100.0%) | 0.12% +0.121 pp | 0.00% +0.002 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 46 | PROFUND ADVISORS LLC | 47.1K +47.1K (+100.0%) | 310.1K +310.1K (+100.0%) | 0.12% +0.119 pp | 0.01% +0.009 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 47 | FLOWER CITY CAPITAL | 42.2K +13.0K (+44.5%) | 277.9K +73.3K (+35.8%) | 0.11% +0.025 pp | 0.14% +0.032 pp | USD4.36 +50.9% | 3 qtrs — |
| 48 | CITIGROUP INC | 37.5K +36.7K (+4,615.7%) | 247.0K +241.4K (+4,332.8%) | 0.09% +0.092 pp | 0.00% +0.000 pp | USD6.52 +0.9% | 18 qtrs — |
| 49 | CI PRIVATE WEALTH, LLC | 35.9K -220.0 (-0.6%) | 236.0K -16.6K (-6.6%) | 0.09% -0.010 pp | 0.00% 0.000 pp | USD3.37 +95.3% | 13 qtrs — |
| 50 | TWO SIGMA ADVISERS, LP | 31.8K +31.8K (+100.0%) | 209.2K +209.2K (+100.0%) | 0.08% +0.080 pp | 0.00% +0.000 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 51 | ENTRYPOINT CAPITAL, LLC | 31.2K +31.2K (+100.0%) | 205.5K +205.5K (+100.0%) | 0.08% +0.079 pp | 0.08% +0.080 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 52 | LPL FINANCIAL LLC | 29.1K +6.7K (+30.0%) | 191.6K +34.8K (+22.2%) | 0.07% +0.011 pp | 0.00% +0.000 pp | USD6.90 -4.6% | 2 qtrs — |
| 53 | CIBC PRIVATE WEALTH GROUP, LLC | 28.5K -21.6K (-43.1%) | 187.5K -162.8K (-46.5%) | 0.07% -0.067 pp | 0.00% 0.000 pp | USD5.74 +14.6% | 6 qtrs — |
| 54 | FIRST MANHATTAN CO. LLC. | 24.2K +— (+0.0%) | 159.5K -10.2K (-6.0%) | 0.06% -0.006 pp | 0.00% +0.000 pp | USD2.20 +199.1% | 8 qtrs — |
| 55 | ALETHEA CAPITAL MANAGEMENT, LLC | 22.9K +— (+0.0%) | 150.9K -9.6K (-6.0%) | 0.06% -0.006 pp | 0.07% -0.030 pp | USD3.37 +95.3% | 3 qtrs — |
| 56 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 22.3K +— (+0.0%) | 147.0K -9.4K (-6.0%) | 0.06% -0.006 pp | 0.00% +0.000 pp | USD4.06 +62.1% | 4 qtrs — |
| 57 | RESONANT CAPITAL ADVISORS, LLC | 20.0K +— (+0.0%) | 131.6K -8.4K (-6.0%) | 0.05% -0.005 pp | 0.01% -0.001 pp | USD7.00 -6.0% | 2 qtrs — |
| 58 | PNC FINANCIAL SERVICES GROUP, INC. | 20.0K +— (+0.0%) | 131.6K -8.4K (-6.0%) | 0.05% -0.005 pp | 0.00% +0.000 pp | USD7.65 -14.0% | 10 qtrs — |
| 59 | TIDEMARK, LLC | 20.0K -24.4K (-55.0%) | 131.6K -179.2K (-57.7%) | 0.05% -0.073 pp | 0.04% -0.053 pp | USD2.49 +164.3% | 6 qtrs — |
| 60 | DIMENSIONAL FUND ADVISORS LP | 19.6K +— (+0.0%) | 128.7K -8.2K (-6.0%) | 0.05% -0.005 pp | 0.00% +0.000 pp | USD5.89 +11.7% | 10 qtrs — |
| 61 | GREAT VALLEY ADVISOR GROUP, INC. | 19.0K +19.0K (+100.0%) | 125.0K +125.0K (+100.0%) | 0.05% +0.048 pp | 0.00% +0.002 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 62 | LIGHTHOUSE INVESTMENT PARTNERS, LLC | 17.8K +17.8K (+100.0%) | 116.9K +116.9K (+100.0%) | 0.04% +0.045 pp | 0.00% +0.004 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 63 | NATIONS FINANCIAL GROUP INC, /IA/ /ADV | 16.0K +16.0K (+100.0%) | 105.3K +105.3K (+100.0%) | 0.04% +0.040 pp | 0.01% +0.006 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 64 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 15.5K +10.5K (+210.4%) | 102.1K +67.1K (+191.8%) | 0.04% +0.025 pp | 0.01% +0.005 pp | USD6.72 -2.1% | 2 qtrs — |
| 65 | WENDELL DAVID ASSOCIATES INC | 15.0K +— (+0.0%) | 99.0K -6.0K (-5.7%) | 0.04% -0.004 pp | 0.01% 0.000 pp | USD7.00 -6.0% | 2 qtrs — |
| 66 | WELLS FARGO & COMPANY/MN | 15.0K +— (+0.0%) | 98.7K -6.3K (-6.0%) | 0.04% -0.004 pp | 0.00% +0.000 pp | USD4.58 +43.7% | 3 qtrs — |
| 67 | FUTURE FINANCIAL WEALTH MANAGMENT LLC | 18.0K +13.0K (+260.0%) | 86.0K +51.0K (+145.8%) | 0.05% +0.032 pp | 0.06% +0.036 pp | USD6.70 -1.8% | 2 qtrs — |
| 68 | SIMPLEX TRADING, LLC | 13.0K +13.0K (+100.0%) | 85.2K +85.2K (+100.0%) | 0.03% +0.033 pp | 0.00% +0.000 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 69 | AUSDAL FINANCIAL PARTNERS, INC. | 11.0K +11.0K (+100.0%) | 72.4K +72.4K (+100.0%) | 0.03% +0.028 pp | 0.00% +0.003 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 70 | SUMMITTX CAPITAL, L.P. | 10.5K +10.5K (+100.0%) | 68.9K +68.9K (+100.0%) | 0.03% +0.026 pp | 0.00% +0.002 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 71 | MOORS & CABOT, INC. | 10.0K -1.0K (-9.1%) | 65.8K -11.2K (-14.5%) | 0.03% -0.005 pp | 0.00% -0.001 pp | USD7.00 -6.0% | 2 qtrs — |
| 72 | MERCER GLOBAL ADVISORS INC /ADV | 10.0K +— (+0.0%) | 65.8K -4.2K (-6.0%) | 0.03% -0.003 pp | 0.00% +0.000 pp | USD7.00 -6.0% | 2 qtrs — |
| 73 | VONTOBEL HOLDING LTD. | 10.0K -11.5K (-53.5%) | 65.7K -84.3K (-56.2%) | 0.03% -0.035 pp | 0.00% 0.000 pp | USD7.00 -6.0% | 2 qtrs — |
| 74 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 7.6K +7.6K (+100.0%) | 51.3K +51.3K (+100.0%) | 0.02% +0.019 pp | 0.00% +0.000 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 75 | JPMORGAN CHASE & CO | 6.8K +5.3K (+351.0%) | 44.5K +34.0K (+323.9%) | 0.02% +0.013 pp | 0.00% +0.000 pp | USD7.01 -6.1% | 18 qtrs — |
| 76 | CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 5.0K +5.0K (+100.0%) | 32.9K +32.9K (+100.0%) | 0.01% +0.013 pp | 0.01% +0.008 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 77 | ADVISOR GROUP HOLDINGS, INC. | 4.3K +— (+0.0%) | 28.3K -1.8K (-6.0%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD3.37 +95.3% | 3 qtrs — |
| 78 | MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 3.1K +3.1K (+100.0%) | 20.6K +20.6K (+100.0%) | 0.01% +0.008 pp | 0.00% +0.000 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 79 | BNP PARIBAS ARBITRAGE, SNC | 2.2K +2.0K (+755.0%) | 14.7K +12.9K (+703.7%) | 0.01% +0.005 pp | 0.00% +0.000 pp | USD6.07 +8.4% | 5 qtrs — |
| 80 | FLAGSHIP HARBOR ADVISORS, LLC | 1.5K +1.5K (+100.0%) | 9.9K +9.9K (+100.0%) | 0.00% +0.004 pp | 0.00% +0.001 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 81 | GF FUND MANAGEMENT CO. LTD. | 1.3K +1.3K (+100.0%) | 8.3K +8.3K (+100.0%) | 0.00% +0.003 pp | 0.00% +0.000 pp | USD6.58 +0.0% | 1 qtrs NEW |
| 82 | EVERSOURCE WEALTH ADVISORS, LLC | 345.00 -87.0 (-20.1%) | 2.3K -754.0 (-24.9%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.34 +181.2% | 7 qtrs — |
| 83 | TOWER RESEARCH CAPITAL LLC (TRC) | 107.00 +107.0 (+100.0%) | 704.00 +704.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.58 +0.0% | 18 qtrs — |
| 84 | JONES FINANCIAL COMPANIES LLLP | 30.00 +30.0 (+100.0%) | 197.00 +197.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.57 +0.2% | 1 qtrs NEW |
| 85 | GSA CAPITAL PARTNERS LLP | — -37.8K (-100.0%) | — -265.0K (-100.0%) | 0.00% -0.105 pp | 0.00% -0.022 pp | USD— | 2 qtrs SOLD |
| 86 | MONASHEE INVESTMENT MANAGEMENT LLC | — -300.0K (-100.0%) | — -2.1M (-100.0%) | 0.00% -0.834 pp | 0.00% -1.047 pp | USD— | 2 qtrs SOLD |
| 87 | LOGOS GLOBAL MANAGEMENT LP | — -950.0K (-100.0%) | — -6.7M (-100.0%) | 0.00% -2.640 pp | 0.00% -0.596 pp | USD— | 2 qtrs SOLD |
| 88 | EXODUSPOINT CAPITAL MANAGEMENT, LP | — -1.5M (-100.0%) | — -10.6M (-100.0%) | 0.00% -4.215 pp | 0.00% -0.109 pp | USD— | 2 qtrs SOLD |
| 89 | AWM INVESTMENT COMPANY, INC. | — -150.0K (-100.0%) | — -1.1M (-100.0%) | 0.00% -0.417 pp | 0.00% -0.098 pp | USD— | 2 qtrs SOLD |
| 90 | AVIDITY PARTNERS MANAGEMENT LP | — -90.9K (-100.0%) | — -636.3K (-100.0%) | 0.00% -0.253 pp | 0.00% -0.145 pp | USD— | 2 qtrs SOLD |
| 91 | VIRTU FINANCIAL LLC | — -14.0K (-100.0%) | — -98.0K (-100.0%) | 0.00% -0.039 pp | 0.00% -0.006 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 44 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | ALPS Medical Breakthroughs ETF SBIO | 0.17% | 361.0K | 0.50% |
| 2 | iShares Micro-Cap ETF IWC | 0.06% | 921.5K | 0.60% |
| 3 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.03% | 279.8K | 0.35% |
| 4 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.03% | 18.7K | 0.35% |
| 5 | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF GSSC | 0.02% | 242.4K | 0.20% |
| 6 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.02% | 105.1K | 0.40% |
| 7 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.02% | 17.0K | 0.19% |
| 8 | iShares Biotechnology ETF IBB | 0.02% | 2.02M | 0.44% |
| 9 | iShares Russell 2000 Value ETF IWN | 0.02% | 2.51M | 0.24% |
| 10 | ProShares Ultra Nasdaq Biotechnology BIB | 0.01% | 11.1K | 1.19% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
14
Sells
0
Shares acquired
1.84M
Shares disposed
—
Cash buys
5.00
Cash sales
—
Net activity
+1,835,595
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-13 | Neufeld Leah R | Officer | A-Award | A | Class A Common Stock | 3,628 | 4.29 | 15.6K | 29,598 | D | ↗ |
| 2026-02-03 | Zeskind Benjamin J. | Director / Officer | A-Award | A | Stock Option | 688,000 | 4.91 | 3.38M | 688,000 | D | ↗ |
| 2026-02-03 | Neufeld Leah R | Officer | A-Award | A | Stock Option | 140,000 | 4.91 | 687.4K | 140,000 | D | ↗ |
| 2026-02-03 | Morales Mallory | Officer | A-Award | A | Stock Option | 140,000 | 4.91 | 687.4K | 140,000 | D | ↗ |
| 2026-02-03 | Matushansky Igor | Officer | A-Award | A | Stock Option | 140,000 | 4.91 | 687.4K | 140,000 | D | ↗ |
| 2026-02-03 | Hall Brett Matthew | Officer | A-Award | A | Stock Option | 344,000 | 4.91 | 1.69M | 344,000 | D | ↗ |
| 2026-02-03 | Brakewood Harold Eugene | Officer | A-Award | A | Stock Option | 140,000 | 4.91 | 687.4K | 140,000 | D | ↗ |
| 2026-02-03 | Bookman Michael | Officer | A-Award | A | Stock Option | 176,000 | 4.91 | 864.2K | 176,000 | D | ↗ |
| 2026-01-16 | Brakewood Harold Eugene | Officer | P-Purchase | A | Class A Common Stock | 5,250 | 4.76 | 25.0K | 11,050 | D | ↗ |
| 2026-01-15 | Schall Thomas J. | Director | P-Purchase | A | Class A Common Stock | 21,645 | 4.67 | 101.0K | 74,530 | D | ↗ |
| 2026-01-15 | Hall Brett Matthew | Officer | P-Purchase | A | Class A Common Stock | 2,298 | 4.57 | 10.5K | 376,496 | D | ↗ |
| 2026-01-13 | Neufeld Leah R | Officer | P-Purchase | A | Class A Common Stock | 2,626 | 4.15 | 10.9K | 25,970 | D | ↗ |
| 2026-01-12 | Feinberg Peter | Director | P-Purchase | A | Class A Common Stock | 20,000 | 4.35 | 86.9K | 135,441 | I | ↗ |
| 2026-01-01 | KEATING LAURIE | Director | A-Award | A | Stock Option | 7,888 | 6.58 | 51.9K | 7,888 | D | ↗ |
| 2026-01-01 | Feinberg Peter | Director | A-Award | A | Stock Option | 7,888 | 6.58 | 51.9K | 7,888 | D | ↗ |
| 2025-10-03 | Feinberg Peter | Director | P-Purchase | A | Class A Common Stock | 7,500 | 6.67 | 50.0K | 156,766 | D | ↗ |
| 2025-10-01 | Neufeld Leah R | Officer | P-Purchase | A | Class A Common Stock | 800 | 6.38 | 5.1K | 23,344 | D | ↗ |
| 2025-10-01 | Morales Mallory | Officer | P-Purchase | A | Class A Common Stock | 300 | 6.39 | 1.9K | 27,533 | D | ↗ |
| 2025-10-01 | Bookman Michael | Officer | P-Purchase | A | Class A Common Stock | 1,020 | 6.83 | 7.0K | 4,870 | D | ↗ |
| 2025-09-30 | Feinberg Peter | Director | P-Purchase | A | Class A Common Stock | 7,500 | 7.03 | 52.7K | 149,266 | D | ↗ |
| 2025-09-29 | Feinberg Peter | Director | P-Purchase | A | Class A Common Stock | 5,000 | 7.18 | 35.9K | 141,766 | D | ↗ |
| 2025-09-15 | Neufeld Leah R | Officer | A-Award | A | Class A Common Stock | 11,815 | 1.43 | 16.9K | 22,544 | D | ↗ |
| 2025-09-15 | Morales Mallory | Officer | A-Award | A | Class A Common Stock | 14,497 | 1.43 | 20.7K | 27,233 | D | ↗ |
| 2025-09-15 | Hall Brett Matthew | Officer | A-Award | A | Class A Common Stock | 14,880 | 1.43 | 21.2K | 374,198 | D | ↗ |
| 2025-07-02 | Zeskind Benjamin J. | Director / Officer / 10% Owner | P-Purchase | A | Class A Common Stock | 7,015 | 3.53 | 24.8K | 2,312,852 | D | ↗ |
| 2025-07-02 | Neufeld Leah R | Officer | P-Purchase | A | Class A Common Stock | 700 | 3.57 | 2.5K | 10,729 | D | ↗ |
| 2025-07-02 | HAUSMAN DIANA | Director | P-Purchase | A | Class A Common Stock | 2,500 | 3.60 | 9.0K | 2,500 | D | ↗ |
| 2025-07-01 | Zeskind Benjamin J. | Director / Officer / 10% Owner | P-Purchase | A | Class A Common Stock | 2,985 | 3.38 | 10.1K | 2,305,837 | D | ↗ |
| 2025-06-27 | Schall Thomas J. | Director | P-Purchase | A | Class A Common Stock | 9,500 | 3.66 | 34.8K | 52,885 | D | ↗ |
| 2025-06-23 | Hall Brett Matthew | Officer | P-Purchase | A | Class A Common Stock | 6,007 | 2.43 | 14.6K | 359,318 | D | ↗ |
| 2025-06-20 | Hall Brett Matthew | Officer | P-Purchase | A | Class A Common Stock | 7,415 | 2.70 | 20.0K | 353,311 | D | ↗ |
| 2025-06-20 | Brakewood Harold Eugene | Officer | P-Purchase | A | Class A Common Stock | 1,900 | 2.53 | 4.8K | 5,800 | D | ↗ |
| 2025-06-18 | Zeskind Benjamin J. | Director / Officer / 10% Owner | P-Purchase | A | Class A Common Stock | 21,000 | 2.39 | 50.1K | 2,302,852 | D | ↗ |
| 2025-06-18 | Feinberg Peter | Director | P-Purchase | A | Class A Common Stock | 25,000 | 2.53 | 63.2K | 136,766 | D | ↗ |
| 2025-06-17 | Schall Thomas J. | Director | P-Purchase | A | Class A Common Stock | 40,485 | 2.21 | 89.3K | 43,385 | D | ↗ |
| 2025-06-13 | Schall Thomas J. | Director | A-Award | A | Stock Option | 33,350 | 1.90 | 63.4K | 33,350 | D | ↗ |
| 2025-06-13 | KEATING LAURIE | Director | A-Award | A | Stock Option | 33,350 | 1.90 | 63.4K | 33,350 | D | ↗ |
| 2025-06-13 | HAUSMAN DIANA | Director | A-Award | A | Stock Option | 33,350 | 1.90 | 63.4K | 33,350 | D | ↗ |
| 2025-06-13 | Feinberg Peter | Director | A-Award | A | Stock Option | 33,350 | 1.90 | 63.4K | 33,350 | D | ↗ |
| 2025-06-13 | CARPENTER ROBERT J | Director | A-Award | A | Stock Option | 33,350 | 1.90 | 63.4K | 33,350 | D | ↗ |
| 2025-06-13 | BERMAN ANN E | Director | A-Award | A | Stock Option | 33,350 | 1.90 | 63.4K | 33,350 | D | ↗ |
| 2025-03-21 | Matushansky Igor | Officer | A-Award | A | Stock Option | 118,000 | 1.80 | 212.4K | 118,000 | D | ↗ |
| 2025-03-17 | Matushansky Igor | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-02-05 | Zeskind Benjamin J. | Director / Officer / 10% Owner | A-Award | A | Stock Option | 480,000 | 1.91 | 916.8K | 480,000 | D | ↗ |
| 2025-02-05 | Neufeld Leah R | Officer | A-Award | A | Stock Option | 110,000 | 1.91 | 210.1K | 110,000 | D | ↗ |
| 2025-02-05 | Morales Mallory | Officer | A-Award | A | Stock Option | 110,000 | 1.91 | 210.1K | 110,000 | D | ↗ |
| 2025-02-05 | Hall Brett Matthew | Officer | A-Award | A | Stock Option | 240,000 | 1.91 | 458.4K | 240,000 | D | ↗ |
| 2025-02-05 | Brakewood Harold Eugene | Officer | A-Award | A | Stock Option | 100,000 | 1.91 | 191.0K | 100,000 | D | ↗ |
| 2025-02-05 | Bookman Michael | Officer | A-Award | A | Stock Option | 110,000 | 1.91 | 210.1K | 110,000 | D | ↗ |
| 2025-01-01 | KEATING LAURIE | Director | A-Award | A | Stock Option | 23,485 | 2.20 | 51.7K | 23,485 | D | ↗ |
| 2025-01-01 | Feinberg Peter | Director | A-Award | A | Stock Option | 23,485 | 2.20 | 51.7K | 23,485 | D | ↗ |
| 2025-01-01 | BERMAN ANN E | Director | A-Award | A | Stock Option | 23,485 | 2.20 | 51.7K | 23,485 | D | ↗ |
| 2024-09-15 | Morales Mallory | Officer | A-Award | A | Class A Common Stock | 4,458 | 1.62 | 7.2K | 12,736 | — | ↗ |
| 2024-06-12 | Schall Thomas J. | Director | A-Award | A | Stock Option | 8,588 | 1.54 | 13.2K | 8,588 | — | ↗ |
| 2024-06-12 | KEATING LAURIE | Director | A-Award | A | Stock Option | 33,350 | 1.54 | 51.4K | 33,350 | — | ↗ |
| 2024-06-12 | HAUSMAN DIANA | Director | A-Award | A | Stock Option | 33,350 | 1.54 | 51.4K | 33,350 | — | ↗ |
| 2024-06-12 | Feinberg Peter | Director | A-Award | A | Stock Option | 33,350 | 1.54 | 51.4K | 33,350 | — | ↗ |
| 2024-06-12 | CARPENTER ROBERT J | Director | A-Award | A | Stock Option | 33,350 | 1.54 | 51.4K | 33,350 | — | ↗ |
| 2024-06-12 | BERMAN ANN E | Director | A-Award | A | Stock Option | 33,350 | 1.54 | 51.4K | 33,350 | — | ↗ |
| 2024-05-21 | Neufeld Leah R | Officer | A-Award | A | Stock Option | 105,000 | 3.01 | 316.1K | 105,000 | — | ↗ |
| 2024-05-21 | Morales Mallory | Officer | D-Return | D | Stock Option | 10,000 | 6.33 | 63.3K | 0 | — | ↗ |
| 2024-05-21 | Brakewood Harold Eugene | Officer | D-Return | D | Stock Option | 165,000 | 9.71 | 1.60M | 0 | — | ↗ |
| 2024-05-21 | Bookman Michael | Officer | D-Return | D | Stock Option | 47,300 | 9.66 | 456.9K | 0 | — | ↗ |
| 2024-04-01 | Cormorant Asset Management, LP | 10% Owner | S-Sale | D | Class A Common Stock | 10 | 3.01 | 30.10 | 3,294,163 | — | ↗ |
| 2024-03-22 | Schall Thomas J. | Director | P-Purchase | A | Class A Common Stock | 2,900 | 2.55 | 7.4K | 2,900 | — | ↗ |
| 2024-03-22 | Morales Mallory | Officer | P-Purchase | A | Class A Common Stock | 393 | 2.55 | 1.0K | 8,278 | — | ↗ |
| 2024-03-22 | Feinberg Peter | Director | P-Purchase | A | Class A Common Stock | 25,000 | 2.55 | 63.7K | 111,766 | — | ↗ |
| 2024-03-22 | Brakewood Harold Eugene | Officer | P-Purchase | A | Class A Common Stock | 3,900 | 2.57 | 10.0K | 3,900 | — | ↗ |
| 2024-03-21 | Morales Mallory | Officer | P-Purchase | A | Class A Common Stock | 1,107 | 2.72 | 3.0K | 7,885 | — | ↗ |
| 2024-03-20 | Neufeld Leah R | Officer | P-Purchase | A | Class A Common Stock | 3,818 | 2.88 | 11.0K | 10,029 | — | ↗ |
| 2024-03-20 | Hall Brett Matthew | Officer | P-Purchase | A | Class A Common Stock | 7,000 | 2.86 | 20.0K | 345,896 | — | ↗ |
| 2024-03-19 | Zeskind Benjamin J. | Director / Officer / 10% Owner | P-Purchase | A | Class A Common Stock | 20,000 | 2.77 | 55.3K | 2,281,852 | — | ↗ |
| 2024-03-19 | Feinberg Peter | Director | P-Purchase | A | Class A Common Stock | 25,000 | 2.56 | 64.0K | 86,766 | — | ↗ |
| 2024-03-18 | Feinberg Peter | Director | P-Purchase | A | Class A Common Stock | 45,024 | 2.31 | 103.9K | 56,790 | — | ↗ |
| 2024-03-18 | BERMAN ANN E | Director | P-Purchase | A | Class A Common Stock | 57,965 | 2.13 | 123.4K | 67,465 | — | ↗ |
| 2024-03-15 | Neufeld Leah R | Officer | A-Award | A | Class A Common Stock | 6,211 | 1.62 | 10.1K | 6,211 | — | ↗ |
| 2024-03-15 | Morales Mallory | Officer | A-Award | A | Class A Common Stock | 4,344 | 1.62 | 7.0K | 6,778 | — | ↗ |
| 2024-03-15 | Hall Brett Matthew | Officer | A-Award | A | Class A Common Stock | 6,211 | 1.62 | 10.1K | 338,896 | — | ↗ |
| 2024-03-15 | Cormorant Asset Management, LP | 10% Owner | S-Sale | D | Class A Common Stock | 400,000 | 2.14 | 856.4K | 3,295,273 | — | ↗ |
| 2024-03-15 | Bookman Michael | Officer | A-Award | A | Class A Common Stock | 1,448 | 1.62 | 2.3K | 3,850 | — | ↗ |
| 2024-03-14 | Cormorant Asset Management, LP | 10% Owner | S-Sale | D | Class A Common Stock | 345,266 | 3.24 | 1.12M | 3,859,098 | — | ↗ |
| 2024-03-11 | Schall Thomas J. | Director | A-Award | A | Stock Option | 35,000 | 5.93 | 207.6K | 35,000 | — | ↗ |
| 2024-02-08 | Zeskind Benjamin J. | Director / Officer / 10% Owner | A-Award | A | Stock Option | 16,414 | 6.70 | 110.0K | 16,414 | — | ↗ |
| 2024-02-08 | Neufeld Leah R | Officer | A-Award | A | Stock Option | 60,500 | 6.09 | 368.4K | 60,500 | — | ↗ |
| 2024-02-08 | Morales Mallory | Officer | A-Award | A | Stock Option | 60,500 | 6.09 | 368.4K | 60,500 | — | ↗ |
| 2024-02-08 | Hall Brett Matthew | Officer | A-Award | A | Stock Option | 130,900 | 6.09 | 797.2K | 130,900 | — | ↗ |
| 2024-02-08 | Brakewood Harold Eugene | Officer | A-Award | A | Stock Option | 60,500 | 6.09 | 368.4K | 60,500 | — | ↗ |
| 2024-02-08 | Bookman Michael | Officer | A-Award | A | Stock Option | 93,000 | 6.09 | 566.4K | 93,000 | — | ↗ |
| 2024-01-01 | KEATING LAURIE | Director | A-Award | A | Stock Option | 6,879 | 7.35 | 50.6K | 6,879 | — | ↗ |
| 2024-01-01 | Feinberg Peter | Director | A-Award | A | Stock Option | 6,879 | 7.35 | 50.6K | 6,879 | — | ↗ |
| 2023-06-14 | KEATING LAURIE | Director | A-Award | A | Stock Option | 17,500 | 9.32 | 163.1K | 17,500 | — | ↗ |
| 2023-06-14 | HAUSMAN DIANA | Director | A-Award | A | Stock Option | 17,500 | 9.32 | 163.1K | 17,500 | — | ↗ |
| 2023-06-14 | Feinberg Peter | Director | A-Award | A | Stock Option | 17,500 | 9.32 | 163.1K | 17,500 | — | ↗ |
| 2023-06-14 | CARPENTER ROBERT J | Director | A-Award | A | Stock Option | 17,500 | 9.32 | 163.1K | 17,500 | — | ↗ |
| 2023-06-14 | BERMAN ANN E | Director | A-Award | A | Stock Option | 17,500 | 9.32 | 163.1K | 17,500 | — | ↗ |
| 2023-06-13 | Morales Mallory | Officer | A-Award | A | Stock Option | 15,000 | 9.55 | 143.3K | 15,000 | — | ↗ |
| 2023-04-20 | Cormorant Asset Management, LP | 10% Owner | — | I | Class A Common Stock | 0 | 0.00 | — | 4,204,364 | — | ↗ |
| 2023-03-31 | Brakewood Harold Eugene | Officer | A-Award | A | Stock Option | 165,000 | 9.71 | 1.60M | 165,000 | — | ↗ |
| 2023-03-27 | Brakewood Harold Eugene | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-02-15 | Zeskind Benjamin J. | Director / Officer / 10% Owner | A-Award | A | Stock Option | 21,756 | 4.68 | 101.8K | 374,000 | — | ↗ |
| 2023-02-15 | Neufeld Leah R | Officer | A-Award | A | Stock Option | 105,000 | 4.25 | 446.3K | 105,000 | — | ↗ |
| 2023-02-15 | Morales Mallory | Officer | A-Award | A | Stock Option | 72,000 | 4.25 | 306.0K | 72,000 | — | ↗ |
| 2023-02-15 | Hall Brett Matthew | Officer | A-Award | A | Stock Option | 187,000 | 4.25 | 794.8K | 187,000 | — | ↗ |
| 2023-02-15 | Bookman Michael | Officer | A-Award | A | Stock Option | 143,000 | 4.25 | 607.8K | 143,000 | — | ↗ |
| 2023-02-15 | Barrett Scott | Officer | A-Award | A | Stock Option | 110,000 | 4.25 | 467.5K | 110,000 | — | ↗ |
| 2022-12-22 | Zeskind Benjamin J. | Director | M-Exempt | A | Class A Common Stock | 2,500 | 3.01 | 7.5K | 2,261,852 | — | ↗ |
| 2022-10-31 | Neufeld Leah R | Director / Officer | A-Award | A | Stock Option | 88,600 | 0.00 | — | 88,600 | — | ↗ |
| 2022-10-17 | Neufeld Leah R | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-08-11 | Morales Mallory | Director | A-Award | A | Stock Option | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-06-21 | KEATING LAURIE | Director | A-Award | A | Stock Option | 14,200 | 0.00 | — | 14,200 | — | ↗ |
| 2022-06-21 | HAUSMAN DIANA | Director | A-Award | A | Stock Option | 6,185 | 0.00 | — | 6,185 | — | ↗ |
| 2022-06-21 | Feinberg Peter | Director | A-Award | A | Stock Option | 14,200 | 0.00 | — | 14,200 | — | ↗ |
| 2022-06-21 | CARPENTER ROBERT J | Director | A-Award | A | Stock Option | 14,200 | 0.00 | — | 14,200 | — | ↗ |
| 2022-06-21 | BERMAN ANN E | Director | A-Award | A | Stock Option | 14,200 | 4.63 | 65.7K | 14,200 | — | ↗ |
| 2022-05-25 | Hall Brett Matthew | Director / Officer | P-Purchase | A | Class A Common Stock | 2,551 | 3.92 | 10.0K | 332,685 | — | ↗ |
| 2022-05-17 | Bookman Michael | Director | P-Purchase | A | Class A Common Stock | 1,000 | 4.88 | 4.9K | 2,402 | — | ↗ |
| 2022-05-16 | KEATING LAURIE | Director | P-Purchase | A | Class A Common Stock | 7,000 | 5.00 | 35.0K | 14,000 | — | ↗ |
| 2022-05-12 | Amin Biren | Director | P-Purchase | A | Class A Common Stock | 1,000 | 4.42 | 4.4K | 7,898 | — | ↗ |
| 2022-04-12 | Zeskind Benjamin J. | Director | M-Exempt | A | Class A Common Stock | 2,000 | 3.01 | 6.0K | 2,259,352 | — | ↗ |
| 2022-03-23 | Zeskind Benjamin J. | Director | P-Purchase | A | Class A Common Stock | 3,000 | 8.02 | 24.1K | 2,257,352 | — | ↗ |
| 2022-03-23 | Hall Brett Matthew | Director / Officer | P-Purchase | A | Class A Common Stock | 1,050 | 7.91 | 8.3K | 330,134 | — | ↗ |
| 2022-03-22 | Barrett Scott | Director / Officer | P-Purchase | A | Class A Common Stock | 900 | 7.49 | 6.7K | 7,563 | — | ↗ |
| 2022-03-15 | Feinberg Peter | Director | P-Purchase | A | Class A Common Stock | 6,667 | 6.75 | 45.0K | 11,766 | — | ↗ |
| 2022-03-15 | BERMAN ANN E | Director | P-Purchase | A | Class A Common Stock | 6,000 | 6.40 | 38.4K | 9,500 | — | ↗ |
| 2022-02-28 | Zeskind Benjamin J. | Director / Officer / 10% Owner | M-Exempt | A | Class A Common Stock | 2,000 | 3.01 | 6.0K | 2,254,352 | — | ↗ |
| 2022-02-10 | Zeskind Benjamin J. | Director / Officer / 10% Owner | A-Award | A | Stock Option | 45,615 | 10.63 | 484.9K | 202,100 | — | ↗ |
| 2022-02-10 | Hall Brett Matthew | Officer | A-Award | A | Stock Option | 83,100 | 9.66 | 802.7K | 83,100 | — | ↗ |
| 2022-02-10 | Bookman Michael | Officer | A-Award | A | Stock Option | 47,300 | 9.66 | 456.9K | 47,300 | — | ↗ |
| 2022-02-10 | Barrett Scott | Officer | A-Award | A | Stock Option | 71,850 | 9.66 | 694.1K | 71,850 | — | ↗ |
| 2022-02-10 | Amin Biren | Officer | A-Award | A | Stock Option | 70,050 | 9.66 | 676.7K | 70,050 | — | ↗ |
| 2022-01-14 | HAUSMAN DIANA | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | Zeskind Benjamin J. | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-22 | Hall Brett Matthew | Officer | A-Award | A | Class A Common Stock | 322,691 | 0.00 | — | 329,084 | — | ↗ |
| 2021-09-20 | Feinberg Peter | Director | P-Purchase | A | Class A Common Stock | 4,750 | 24.45 | 116.1K | 5,099 | — | ↗ |
| 2021-09-13 | Zeskind Benjamin J. | Director / Officer / 10% Owner | P-Purchase | A | Class A Common Stock | 2,083 | 22.87 | 47.6K | 2,602,352 | — | ↗ |
| 2021-09-13 | Feinberg Peter | Director | P-Purchase | A | Class A Common Stock | 5,750 | 21.51 | 123.7K | 392,242 | — | ↗ |
| 2021-08-03 | Zeskind Benjamin J. | Director / Officer / 10% Owner | C-Conversion | D | Series A Preferred Stock | 40,928 | 0.00 | — | 0 | — | ↗ |
| 2021-08-03 | KEATING LAURIE | Director | P-Purchase | A | Class A Common Stock | 7,000 | 15.00 | 105.0K | 7,000 | — | ↗ |
| 2021-08-03 | Hall Brett Matthew | Officer | P-Purchase | A | Class A Common Stock | 1,353 | 15.00 | 20.3K | 6,393 | — | ↗ |
| 2021-08-03 | Feinberg Peter | Director | C-Conversion | A | Class A Common Stock | 123,155 | 0.00 | — | 347,401 | — | ↗ |
| 2021-08-03 | Cormorant Asset Management, LP | — | P-Purchase | A | Common Stock | 550,000 | 15.00 | 8.25M | 2,252,628 | — | ↗ |
| 2021-08-03 | CARPENTER ROBERT J | Director | P-Purchase | A | Class A Common Stock | 325,000 | 15.00 | 4.88M | 1,148,839 | — | ↗ |
| 2021-08-03 | Bookman Michael | Officer | P-Purchase | A | Class A Common Stock | 1,402 | 15.00 | 21.0K | 1,402 | — | ↗ |
| 2021-08-03 | Barrett Scott | Officer | P-Purchase | A | Class A Common Stock | 667 | 15.00 | 10.0K | 6,663 | — | ↗ |
| 2021-08-03 | BERMAN ANN E | Director | P-Purchase | A | Class A Common Stock | 3,500 | 15.00 | 52.5K | 3,500 | — | ↗ |
| 2021-08-03 | Amin Biren | Officer | P-Purchase | A | Class A Common Stock | 4,175 | 15.00 | 62.6K | 6,898 | — | ↗ |
| 2021-07-29 | Zeskind Benjamin J. | Director / Officer / 10% Owner | — | D | Stock Option | 175,000 | 9.74 | 1.70M | 0 | — | ↗ |
| 2021-07-29 | KEATING LAURIE | Director | — | D | Stock Option | 60,074 | 4.12 | 247.5K | 0 | — | ↗ |
| 2021-07-29 | Hall Brett Matthew | Officer | — | D | Stock Option | 201,600 | 3.01 | 606.8K | 0 | — | ↗ |
| 2021-07-29 | Feinberg Peter | Director | — | I | Series B Preferred Stock | 30,646 | 0.00 | — | 0 | — | ↗ |
| 2021-07-29 | Cormorant Asset Management, LP | 10% Owner | — | I | Series B Convertible Preferred Stock | 1,702,628 | 0.00 | — | 0 | — | ↗ |
| 2021-07-29 | CARPENTER ROBERT J | Director | — | D | Series A Preferred Stock | 94,585 | 0.00 | — | 0 | — | ↗ |
| 2021-07-29 | Bookman Michael | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-07-29 | Barrett Scott | Officer | — | D | Stock Option | 194,740 | 3.01 | 586.2K | 0 | — | ↗ |
| 2021-07-29 | BERMAN ANN E | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-07-29 | Amin Biren | Officer | — | D | Stock Option | 284,340 | 9.74 | 2.77M | 0 | — | ↗ |
| 2008-09-17 | SAINTS CAPITAL EVEREST LP | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 1,176,471 | — | ↗ |
| 2008-05-30 | LOVE RICHARD L | Director | A-Award | A | Common Stock | 23,810 | 0.00 | — | 48,810 | — | ↗ |
| 2007-12-18 | ONTIVEROS KEVIN | Officer | A-Award | A | Stock Option | 87,335 | 2.10 | 183.4K | 87,335 | — | ↗ |
| 2007-12-18 | LOVE RICHARD L | Director | A-Award | A | Stock Option | 3,333 | 2.11 | 7.0K | 3,333 | — | ↗ |
| 2007-07-31 | ONTIVEROS KEVIN | Officer | A-Award | A | Stock Option (right to buy) | 30,665 | 5.00 | 153.3K | 30,665 | — | ↗ |
| 2007-07-31 | LOVE RICHARD L | Director | A-Award | A | Common Stock | 15,000 | 5.00 | 75.0K | 25,000 | — | ↗ |
| 2007-07-26 | LOVE RICHARD L | Director | P-Purchase | A | Common Stock | 10,000 | 5.00 | 50.0K | 10,000 | — | ↗ |
| 2007-07-25 | ONTIVEROS KEVIN | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2007-07-25 | LOVE RICHARD L | Director | — | D | Stock Option (Right to Buy) | 11,000 | 25.00 | 275.0K | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
36.30M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Benjamin J. Zeskind, Ph.D. President and Chief Executive Officer | 641.5K | 423.4K | — | 579.5K | — | 16.2K | 1.66M | 34.90% | ↗ |
| 2 | 2025 | Brett Hall, Ph.D. Chief Scientific Officer | 733.5K | 264.0K | — | 289.8K | — | 2.2K | 1.29M | 22.47% | ↗ |
| 3 | 2025 | Michael D. Bookman Chief Legal Officer | 502.1K | 241.0K | — | 132.8K | — | 14.5K | 890.4K | 14.92% | ↗ |
| 4 | 2024 | Benjamin J. Zeskind, Ph.D. President and Chief Executive Officer | 616.8K | 308.4K | — | 1.00M | — | 16.1K | 1.95M | 51.61% | ↗ |
| 5 | 2024 | Brett Hall, Ph.D. Chief Scientific Officer | 705.3K | 211.6K | — | 507.4K | — | 1.3K | 1.43M | 35.59% | ↗ |
| 6 | 2024 | Michael D. Bookman Chief Legal Officer | 482.8K | 193.1K | — | 398.4K | — | 14.1K | 1.09M | 36.61% | ↗ |
| 7 | 2023 | Benjamin J. Zeskind, Ph.D. President and Chief Executive Officer | 593.1K | 326.2K | — | 983.1K | — | 15.8K | 1.92M | 51.25% | ↗ |
| 8 | 2023 | Harold "E.B." Brakewood Chief Business Officer | 326.9K | 142.9K | — | 991.0K | — | 13.1K | 1.47M | 67.23% | ↗ |
| 9 | 2023 | Brett Hall, Ph.D. Chief Scientific Officer | 678.1K | 223.8K | — | 493.9K | — | 3.5K | 1.40M | 35.30% | ↗ |
| 10 | 2022 | Benjamin J. Zeskind, Ph.D. President and Chief Executive Officer | 570.3K | 313.7K | — | 1.16M | — | 14.5K | 2.05M | 56.28% | ↗ |
| 11 | 2022 | Brett Hall, Ph.D. Chief Scientific Officer | 652.1K | 215.2K | — | 487.2K | — | 690.00 | 1.36M | 35.95% | ↗ |
| 12 | 2022 | Scott Barrett, M.D. Chief Medical Officer | 504.0K | 138.6K | — | 421.2K | — | 14.2K | 1.08M | 39.08% | ↗ |
| 13 | 2021 | Biren Amin Chief Financial Officer | 312.5K | 180.0K | — | 2.77M | — | 11.6K | 3.27M | 84.60% | ↗ |
| 14 | 2021 | Brett Hall, Ph. D Chief Scientific Officer | 630.0K | 189.0K | — | 1.70M | — | 690.00 | 2.52M | 67.53% | ↗ |
| 15 | 2021 | Benjamin J. Zeskind, Ph.D. President and Chief Executive Officer | 400.2K | 421.0K | — | 1.05M | — | 18.5K | 1.89M | 55.61% | ↗ |
| 16 | 2021 | Brett Hall, Ph.D. Chief Scientific Officer | 630.0K | 189.0K | — | 1.05M | — | 690.00 | 1.87M | 56.21% | ↗ |
| 17 | 2020 | Benjamin J. Zeskind, Ph.D. President and Chief Executive Officer | 292.6K | 500.0K | — | — | — | 13.5K | 806.0K | 0.00% | ↗ |
| 18 | 2020 | Brett Hall, Ph. D Chief Scientific Officer | 615.0K | 160.0K | — | — | — | 200.00 | 775.2K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Benjamin J. Zeskind | Co-Founder, President, Chief Executive Officer & Director | 1M | — |
| Brett Hall | Chief Scientific Officer | 999.8K | — |
| Michael D. Bookman | Chief Legal Officer & Secretary | 757.6K | male |
| Igor Matushansky | Chief Medical Officer | 656.8K | — |
| Harold E. Brakewood | Chief Business Officer | 579.8K | male |
| Robert J. Carpenter | Co-Founder & Chair Emeritus | 45.0K | male |
| Mallory Morales | Senior VP of Finance, Chief Accounting Officer & Treasurer | — | female |
| Leah R. Neufeld | Chief People Officer | — | female |
| Paula George | Director of Accounting & Operations and Assistant Corporation Controller | — | female |
| Peter King | Head of Discovery & Vice President | — | — |
| Praveen Nair | Head of Translational Pharmacology & Vice President | — | — |
| Courtney Dugan | VP and Head of Investor Relations & Corporate Communications | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IMRX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
